Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
about
MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cellsCurrent hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsThe base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrityEpigenetics of colorectal cancerReview of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsClinical management of localized colon cancer with capecitabineModulation of mismatch repair and genomic stability by miR-155Molecular origins of cancer: Molecular basis of colorectal cancerMicrosatellite instability in colorectal cancerMicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroupsThe immunogenicity of colorectal cancers with high-degree microsatellite instabilityPredictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of OptionsA Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerSerrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapyColorectal cancer tumour markers and biomarkers: Recent therapeutic advancesImplications of mismatch repair-deficient status on management of early stage colorectal cancerMolecular Dimensions of Gastric Cancer: Translational and Clinical PerspectivesDeficient mismatch repair: Read all about it (Review)Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancerEvolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision MedicineImproving survival after endometrial cancer: the big picturePrognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Molecular alterations and biomarkers in colorectal cancerTumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes?Colorectal Cancer Biomarkers: Where Are We Now?Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapyThe promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future PerspectiveBiomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and othersGenetic factors affecting patient responses to pancreatic cancer treatmentRole of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerThe molecular background of mucinous carcinoma beyond MUC2Genetics and Genetic Biomarkers in Sporadic Colorectal CancerAspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiencyMicrosatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastasesPAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapyCarcinogenesis and microsatellite instability: the interrelationship between genetics and epigeneticsHereditary and familial colon cancerA review of the clinical relevance of mismatch-repair deficiency in ovarian cancer
P2860
Q21133026-453A962A-64EE-4890-898F-B63534604867Q21328691-0C917837-BD42-43A1-BC7B-299626C5EAECQ24299652-345C1547-C830-4FDF-87EA-FA0B62CF0131Q24598045-377113A7-1CBB-4CF3-9068-972301CB92EBQ24610838-A54539E7-449F-4EF3-B917-7BDBA496C2C3Q24611758-B0792F75-67A1-49D7-95AD-532422C4767AQ24612859-67390D94-FBBF-4D25-B263-92952A5A6EA2Q24617331-C48BC3F8-3346-41C7-AE16-E7D92E0CDA8EQ24627393-E2D1C2CE-B667-4F26-94E0-659EBC32525DQ24630209-DA5837A2-6408-43B2-A905-113A1FC4D644Q24653738-75B8B2DC-C598-49AF-9BCD-796B558FAF31Q24814928-37B98431-F64C-40C5-A3AD-F9B7E556BFF0Q26738655-28E9F42F-B371-4DC4-9082-7B0116FA50AFQ26739607-F0D71FD0-D5E5-436B-926F-B90EB5F54F21Q26751035-AEB1CDD4-5B9B-4EFF-9451-85EDFF541FEDQ26768427-86AE93CF-F49B-4ED3-8CA5-9966781233EFQ26772272-04289622-F026-428D-A334-A4642E161458Q26779725-74C9D065-134A-4BA9-8DC9-0DB030F267A7Q26796491-C0DD4D63-9B6D-45EE-A348-E494A69AE749Q26797255-8DC136D6-C256-4333-9FDE-82570A175E41Q26800355-36FA2660-DA52-45BC-BA06-074907A0AF66Q26801354-B3D94656-5972-49EE-8F69-7469662EB28AQ26830362-720FAED7-ECC1-40A8-A1CE-A020704CAAB9Q26862317-8BAFBA70-1453-47C3-B9AF-D6F70CCF72A5Q26864622-23A1E25A-934F-425F-B91C-CB764A688013Q27003134-9E0C0540-05A2-4BB8-87DB-6BA7C97842FCQ27851526-A612A7CE-39CC-4A00-A7AA-F88E1E8566FDQ28069924-7145ECFC-E4EF-403D-BAC4-65F2DA5E0DFBQ28070038-B6B9F3EE-8F6B-4D4A-8680-53CEF9947075Q28072468-2189FE5D-ED02-4CAE-B70B-46D9300E6528Q28075293-F597E669-1BB1-479A-B0B4-E6FF72DCC476Q28080176-8618D436-95CE-471E-AFF5-92DE20CA11E0Q28083904-8CD5ACA6-70D4-4B73-97A6-84F1858E2DBBQ28084346-99F3FE2C-126E-4508-8AE7-2EBA11A410C3Q28210586-3CC9E56E-51A4-45DD-913D-7D11199FF1B7Q28247135-2ECB6046-21C0-4608-B09B-F9E06F93A883Q28252178-2ECE7808-B01D-4A55-ACEB-0C90C1559E55Q28253670-E70510CE-9F50-4C5E-B8F1-5CDC45A22D19Q28280647-847280D3-0AF6-4C12-98C2-2B19B1AD32BBQ28283356-AFB0C746-5652-4EF7-B24E-5150ECB94988
P2860
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@ast
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@en
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@nl
type
label
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@ast
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@en
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@nl
prefLabel
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@ast
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@en
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@nl
P2093
P2860
P3181
P356
P1476
Tumor microsatellite-instabili ...... chemotherapy for colon cancer
@en
P2093
Amy J French
Christine M Ribic
Daniel J Sargent
Dongsheng Tu
Lois E Shepherd
Malcolm J Moore
Mark Redston
Richard M Goldberg
Robert Gryfe
Stanley R Hamilton
P2860
P304
P3181
P356
10.1056/NEJMOA022289
P407
P577
2003-07-17T00:00:00Z